Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Adare Pharma Solutions announced it has strengthened its executive leadership team with two key hires. Robert Muschert has joined Adare as Chief Commercial Officer, and Dr. Vipan Dhall has joined as Chief Scientific Officer.
read more
Wednesday, December 01, 2021
Adare, a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.
read more
Monday, February 12, 2018
ADC Biotechnology (ADC Bio) is developing a ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.
read more
Monday, September 25, 2017
ADC Biotechnology announces it has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.
read more
Adial and Tedor Pharma announced they entered into a collaboration agreement to provide cGMP contract manufacturing services for AD04.
read more
Tuesday, January 07, 2020
ADMA Biologics announced a five-year manufacturing and supply agreement to produce and sell plasma-derived intermediate fractions from ADMA’s FDA approved Immune Globulin manufacturing process.
read more
ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. FDA approval for its ADMA BioCenters plasma ...
read more
Wednesday, September 08, 2021
ADMA Biologics, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the FDA has granted approval for the Company’s in-house aseptic fill-finish ...
read more
AdvantaPure is now a GORE STA-PURE Pump Tubing systems integrator for biopharm and pharmaceutical applications.
read more
Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment...
read more
Tuesday, October 30, 2012
The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is in the process of taking over the Temmler Group. An agreement was reached today with the previous owners. The purchase price will remain ...
read more
Thursday, September 15, 2022
The development of new drug products and forms of therapy is progressing rapidly. For contract developers and manufacturers, this means staying on the cutting edge of production technologies and actively supporting customers with innovative ...
read more
On July 18, 2022, Neil Jones joined Aenova as the new Chief Commercial Officer (CCO) of Aenova Group.
read more
Thursday, October 04, 2012
Aenova, a leading provider of development and manufacturing services for medicines and dietary supplements has named Brad Carlson as its new Vice President of Marketing & Sales for the Americas, effective October 1, 2012. Mr. Carlson brings more ...
read more
Friday, February 12, 2021
Aerami has announced the signing of an exclusive license and development agreement with Hangzhou Chance to develop and commercialize Aerami’s drug device combination product candidate (AER-901).
read more